William Callahan
Director/Board Member at MEDISUN PRECISION MEDICINE LTD.
Profile
William Callahan is an Independent Director at Medisun Precision Medicine Ltd.
since 2015.
He was a Senior Director-Manufacturing Operations at Talphera, Inc. and a Vice President-Operations at Assertio Therapeutics, Inc. from 2002 to 2012.
He obtained an undergraduate degree from San Francisco State University.
William Callahan active positions
| Companies | Position | Start |
|---|---|---|
| MEDISUN PRECISION MEDICINE LTD. | Director/Board Member | 2015-06-30 |
Former positions of William Callahan
| Companies | Position | End |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Operating Officer | 2012-01-31 |
| TALPHERA, INC. | Corporate Officer/Principal | - |
Training of William Callahan
| San Francisco State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TALPHERA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Medisun Precision Medicine Ltd.
 Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
- Stock Market
- Insiders
- William Callahan
